Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: Relationship to CMV disease

Journal of Infectious Diseases

Volumn 185, Issue 12, 2002, Pages 1717-1722

  Nokta, Mostafa A ^a   Holland, Fiona ^b,c   De Gruttola, Victor ^b   Emery, Vincent C ^d   Jacobson, Mark A ^e,f   Griffiths, Paul ^d   Pollard, Richard B ^a   Feinberg, Judith E ^g  

^a University of Texas Medical Branch School of Medicine   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SAN FRANCISCO GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; VALACICLOVIR;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

ACYCLOVIR; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CASE-CONTROL STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HIV INFECTIONS; HUMANS; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; VALINE;

EID: 0037097541     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340651     Document Type: Article

References (34)

1. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS): Clinical findings, diagnosis, and treatment
2. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine
3. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus
4. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial 4
5. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation
6. Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS
7. Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenmia test
8. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS
9. The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in subjects with advanced human immunodeficiency virus disease
10. A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in subjects with advanced human immunodeficiency virus infection
11. Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: Baseline CMV load dictates time to disease and survival
12. Cytomegalovirus retinitis and acquired immunodeficiency syndrome
13. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS)
14. Cytomegalovirus ventriculoencephalitis in AIDS: A syndrome with distinct clinical and pathologic features
15. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: An autopsy study of 30 cases and a review of the literature
16. Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS
17. Cytomegalovirus infection in patients with AIDS
18. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection
19. Interactions between cytomegalovirus immediate-early proteins and the long terminal repeat of human immunodeficiency virus
20. Involvement of cAMP and protein kinase C in cytomegalovirus enhancement of human immunodeficiency virus replication
21. Human cytomegalovirus-mediated enhancement of human immunodeficiency virus type-1 production in monocyte-derived macrophages
22. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2
23. Studies of viral co-factors for human immunodeficiency virus in vitro and in vivo
24. Cytomegalovirus retinitis in AIDS patients: Influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival
25. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients
26. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: A double-blind randomized trial
27. Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: A double-blind, placebo-controlled study
28. Asymptotic distribution theory and efficiency results for case-cohort studies
29. Strategies for cohort sampling under the Cox proportional hazards model: Application to an AIDS clinical trial
30. Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus
31. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease
32. Loss of cytomegalovirus (CMV) viraemia following highly active anti-retroviral therapy in the absence of specific anti-CMV therapy